Morteza Naghavi,Albert Andrew Yen,Mortaza Mark Naghavi
申请号：
US13346811
公开号：
US20120177631A1
申请日:
2012.01.10
申请国别(地区):
US
年份:
2012
代理人:
摘要：
This invention relates to orally ingested compositions for improving cardiovascular health and reducing the overall levels of cholesterol by lowering the levels of low density lipoprotein (LDL) and triglycerides, increasing the level and density of high density lipoprotein (HDL), assisting with blood pressure control, or improve some aspect of cardiovascular function, and thus preferably assisting with cardiovascular health when administered to mammals, including humans.
